Glaucoma Information Links

Sunday 2012 Long Island Optometric Symposium sponsored by North Shore Eye Care - Albany Times Union

Sunday 2012 Long Island Optometric Symposium sponsored by North Shore Eye Care Albany Times Union Leading surgeons from the ophthalmic industry will illustrate how recent breakthroughs in glaucoma management, cataract surgery and the treatment of retinal and macular disorders can help primary eye care doctors preserve vision loss during this Sunday ... and more »

Two Glaucoma Implants Equally Good at 3 Years - Medscape

Two Glaucoma Implants Equally Good at 3 Years Medscape May 11, 2012 (Fort Lauderdale, Florida) — The Ahmed glaucoma valve and the Baerveldt glaucoma implant, the 2 most commonly used glaucoma drainage implants in the United States, are equally successful in the treatment of refractory glaucoma, ...

Almost 50 Percent of the Glaucoma Patient Population Remains Untreated ... - MarketWatch (press release)

Almost 50 Percent of the Glaucoma Patient Population Remains Untreated ... MarketWatch (press release) If you are interested in more information on this research, please send an email to Britni Myers, Corporate Communications, at britni.myers@frost.com, with your full name, company name, job title, telephone number, company email address, ... and more »

Quark Pharmaceuticals Announces Phase 2a Study of PF--04523655 (PF-655) in ... - MarketWatch (press release)

Quark Pharmaceuticals Announces Phase 2a Study of PF--04523655 (PF-655) in ... MarketWatch (press release) The OAG study will evaluate the potential of PF-655 to enhance visual function in glaucoma. Under the amended agreement, should Pfizer assume development and potential commercialization of PF-655 in either or both indications following review of the ... and more »

Study Reveals That Topamax Increases the Risk of Glaucoma for Patients Using ... - San Francisco Chronicle (press release)

Study Reveals That Topamax Increases the Risk of Glaucoma for Patients Using ... San Francisco Chronicle (press release) The CJF hereby reports that a recent Topamax study revealed that using the drug for migraine headaches could lead to an increased risk in the development of glaucoma. (PRWEB) May 08, 2012 The Consumer Justice Foundation, a for-profit corporation whose ... and more »